• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
AMRA MedicalAMRA Medical

AMRA Medical

Precision for Decision

  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Set Up
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Media
  • About Us
    • About AMRA
    • Our Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us

Medical Research

AMRA Headlines as Lead Partner @ The 3rd Annual Obesity and Weight Loss Drug Development Summit!

July 3, 2025

đź“… SAVE THE DATE: July 14th – 16th, 2025 | Boston, MA LINKĂ–PING, Sweden, July 3, 2025 â€“ We are absolutely thrilled to join…

AMRA Shares Latest Findings at the FSHD Society’s 2025 International Research Congress

June 19, 2025

LINKĂ–PING, Sweden, June 19, 2025 AMRA Medical was thrilled to attend the 2025 International Research Congress, hosted by the FSHD Society! The conference,…

New study shows that six out of ten patients with type 2 diabetes (T2D) had metabolic dysfunction-associated steatotic liver disease (MASLD)

June 17, 2025

LINKĂ–PING, Sweden, June 17, 2025  – A newly-published study, led by Mattias Ekstedt’s ectopic fat study group at the Department of Health, Medicine…

Latest Data from SURPASS-3 Trial Gleans Insight Into the Association of Tirzepatide Treatment with Changes in Muscle Composition in Type 2 Diabetes 

May 1, 2025

A recent post-hoc analysis of Lilly’s SURPASS-3 trial unravels the impact of tirzepatide treatment on muscle volume and fat infiltration in individuals with Type 2 Diabetes

Decoding Duchenne Muscular Dystrophy: MRI Study Explores the Relationship Between AMRA’s Muscle Biomarkers and Functional Changes in Individuals with DMD

April 15, 2025

Recent AMRA research examines whether the use of MRI-based biomarkers as surrogate endpoints in DMD clinical trials is feasible, allowing for more informative descriptions of disease severity and progression in DMD

AMRA at MDA 2025 – Presents research from one of the largest natural history studies to date, validating our unique, MRI-based biomarkers for use as endpoints in upcoming FSHD trials

March 14, 2025

LINKĂ–PING, Sweden, March 14, 2025 – AMRA Medical is muscling up for the 2025 Muscular Dystrophy Association’s Clinical and Scientific Conference (MDA…

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 9
  • Go to Next Page »

Primary Sidebar

AMRA Medical
Follow us

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

  • Data Privacy Policy
  • Cookie Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support

Newsletter

© 2025 AMRA Medical AB
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}